Corvus PharmaceuticalsCRVS
13F holders, Q1 2024 (March 31)47holders
2famous investors
$1.78avg. 13F price*
At the end of Q1 2024, 47 institutions reported holding Corvus Pharmaceuticals Inc. (CRVS) in their 13F filings. The largest holders were Orbimed Advisors LLC ($12.4M), Adams Street Partners LLC ($5.8M) and Samlyn Capital, LLC ($4.2M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Corvus Pharmaceuticals Inc.
- CUSIP
- 221015100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $98K |
| Exits | 8 | $259K |
Ownership 47 holders
| Orbimed Advisors LLC | 0.23% | No change | 6,943,654 | $12.4M |
| Adams Street Partners LLC | 2.32% | No change | 3,275,616 | $5.8M |
| Samlyn Capital, LLC | 0.07% | Reduce -5.9% | 2,348,363 | $4.2M |
| Vanguard Group Inc. | 0.00% | Add +10.6% | 1,493,357 | $2.7M |
| Renaissance Technologies | 0.00% | Add +8.4% | 637,032 | $1.1M |
| BlackRock Inc. | 0.00% | Add +0.5% | 522,978 | $931K |
| Towerview LLC | 0.45% | Reduce -12.4% | 382,500 | $681K |
| Geode Capital Management, LLC | 0.00% | Add +3.2% | 371,763 | $662K |
| BVF Inc. | 0.02% | Reduce -73.6% | 361,406 | $643K |
| Morgan Stanley | 0.00% | Add +6.0% | 275,361 | $490K |
| Bridgeway Capital Management, LLC | 0.01% | Add +50.2% | 224,300 | $399K |
| Two Sigma Advisers, LP | 0.00% | Reduce -21.4% | 185,100 | $329K |
| State Street Corp. | 0.00% | Reduce -13.1% | 120,303 | $214K |
| Susquehanna International Group, LLP | 0.00% | Reduce -52.3% | 105,026 | $187K |
| Two Sigma Investments, LP | 0.00% | Reduce -43.3% | 102,449 | $182K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Add +23.6% | 88,008 | $157K |
| Northern Trust Corp. | 0.00% | Reduce -0.1% | 64,949 | $116K |
| Jackson Square Capital, LLC | 0.03% | No change | 63,773 | $114K |
| JPMorgan Chase & Co. | 0.00% | Add +7679.7% | 52,824 | $94K |
| Hikari Power Ltd | 0.01% | No change | 49,959 | $89K |
| Millennium Management | 0.00% | Reduce -43.0% | 23,281 | $41K |
| Quinn Opportunity Partners LLC | 0.00% | New | 22,327 | $40K |
| Commerce Bank | 0.00% | No change | 20,000 | $36K |
| American Century Companies Inc. | 0.00% | Reduce -1.2% | 18,248 | $32K |
| OneDigital Investment Advisors LLC | 0.00% | Add +44.8% | 17,950 | $32K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 15,668 | $28K |
| Virtu Financial LLC | 0.00% | New | 12,570 | $22K |
| Dimensional Fund Advisors LP | 0.00% | No change | 11,924 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +35.4% | 11,511 | $20K |
| Avity Investment Management Inc. | 0.00% | No change | 11,480 | $20K |
| Whittier Trust Co. of Nevada Inc. | 0.00% | No change | 11,200 | $20K |
| Fortem Financial Group, LLC | 0.01% | New | 11,000 | $20K |
| Masso Torrence Wealth Management Inc. | 0.01% | No change | 10,000 | $18K |
| Simplex Trading, LLC | 0.00% | Reduce -81.2% | 9,346 | $16K |
| Rothschild Investment LLC | 0.00% | New | 7,000 | $12K |
| UBS Group AG | 0.00% | Reduce -30.2% | 4,679 | $8K |
| Group One Trading LLC | 0.00% | Reduce -87.4% | 4,604 | $8K |
| Northwest Capital Management Inc | 0.00% | No change | 3,397 | $6K |
| Qube Research & Technologies Ltd | 0.00% | New | 2,378 | $4K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,200 | $2K |
| Rhumbline Advisers | 0.00% | No change | 791 | $1K |
| Wells Fargo & Company | 0.00% | Add +1.9% | 265 | $472 |
| ICA Group Wealth Management, LLC | 0.00% | New | 165 | $294 |
| IFP Advisors, Inc | 0.00% | No change | 24 | $43 |
| Parallel Advisors, LLC | 0.00% | No change | 20 | $36 |
| FMR LLC | 0.00% | New | 17 | $30 |
| Barclays PLC | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is CRVS's weight in each manager's 13F, not the share of Corvus Pharmaceuticals Inc. the manager owns.